PPT-FREEDOMS II TRIAL

Study Design 24month RCT of fingolimod 05 mg and 125 mg vs placebo 3 years into the study 125 mg discontinued and patients placed on 05 mg in blinded manner R

patients placebo calabresi relapse placebo patients relapse calabresi 556 lancet neurol 2014 545 free disability volume fingolimod endpoint months lesions progression adverse

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/385447" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "FREEDOMS II TRIAL" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.